Debt-to-equity of Tourmaline Bio, Inc. from 30 Sep 2021 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tourmaline Bio, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Jun 2025.
  • Tourmaline Bio, Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 2.9%, unchanged year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tourmaline Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 2.9% 0% 0% 30 Jun 2025
Q1 2025 2.5% -3.8% -60% 31 Mar 2025
Q4 2024 2.1% -38% -95% 31 Dec 2024
Q3 2024 2% +25% 30 Sep 2024
Q2 2024 2.9% -30% -91% 30 Jun 2024
Q1 2024 6.2% -3.4% -35% 31 Mar 2024
Q4 2023 40% +34% +598% 31 Dec 2023
Q3 2023 -23% -33% -324% 30 Sep 2023
Q2 2023 33% +25% +332% 30 Jun 2023
Q1 2023 9.6% +3.7% +62% 31 Mar 2023
Q4 2022 5.7% -4.3% -43% 31 Dec 2022
Q3 2022 10% +5.5% +113% 30 Sep 2022
Q2 2022 7.6% 30 Jun 2022
Q1 2022 5.9% 31 Mar 2022
Q4 2021 10% 31 Dec 2021
Q3 2021 4.8% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.